What Has Been The Evolution of the Polymerase Chain Reaction (PCR) Market in Recent Years?
The polymerase chain reaction (pcr) market has seen considerable growth due to a variety of factors.
• The polymerase chain reaction (PCR) market has experienced rapid growth in recent years. It will rise from $11.42 billion in 2024 to $12.67 billion in 2025, showing a compound annual growth rate (CAGR) of 11.0%.
Factors contributing to this growth include the rising number of research facilities, increased patients with chronic and infectious diseases, a higher prevalence of genetic and chronic conditions, population growth, and an aging population.
What Is the Forecasted Market Size and Growth Rate for The Polymerase Chain Reaction (PCR) Market Size In The Coming Years?
The polymerase chain reaction (pcr) market is expected to maintain its strong growth trajectory in upcoming years.
• The polymerase chain reaction (PCR) market is expected to grow rapidly, reaching $18.97 billion by 2029 with a CAGR of 10.6%.
Growth is driven by food safety concerns, molecular diagnostics, personalized medicine, and digital PCR. Key trends include real-time PCR, DNA sequencing, next-gen sequencing, microfluidics, and advanced molecular diagnostic solutions.
What Factors Are Driving Growth In The Polymerase Chain Reaction (PCR) Market?
The escalating need for personalized medicine is predicted to propel the expansion of the polymerase chain reaction (PCR) market in the future. Personalized or precision medicine is a healthcare approach that customizes decisions, practices, interventions, and therapies to fit the unique traits of each patient. This type of medicine is becoming more popular due to advancements in data analytics, the capability to adapt treatment responses to individual patients, and the potential to customize therapies based on unique genetic profiles. Personalized medicine is facilitated by Polymerase Chain Reaction (PCR) by allowing for the enlargement and examination of specific genetic sequences, which in turn allows healthcare professionals to adapt treatment plans according to unique genetic profiles. For example, the Personalized Medicine Coalition, a professional membership group based in the US, reported that in 2022, the approval of 12 new personalized medicines accounted for around 34% of all newly approved therapies, showing a significant rise from previous years. Consequently, the growing need for personalized medicine is leading to the expansion of the polymerase chain reaction market.
What Are The Main Segments Of The Global Polymerase Chain Reaction (PCR) Market?
The polymerase chain reaction (PCR) market covered in this report is segmented –
1) By Type: Conventional Polymerase Chain Reaction, Other Types
2) By Indication: Infectious Diseases, Oncology, Genetic Disorders, Other Indications
3) By Application: Medical, Non-Medical
4) By End User: Hospitals And Clinics, Pharmaceutical And Biotechnology Industries, Diagnostic Centers, Academic And Research Organization
Subsegments:
1) By Conventional Polymerase Chain Reaction: Endpoint Pcr, Gel Electrophoresis-Based Pcr, Reverse Transcription Pcr (Rt-Pcr), Quantitative Pcr (Qpcr) For Gene Expression, Nested Pcr
2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr), Digital Pcr (Dpcr), Multiplex Pcr, Reverse Transcription-Quantitative Pcr (Rt-Qpcr), Isothermal Amplification (Lamp), Next-Generation Pcr (Ngs-Based Pcr Techniques), High-Throughput Pcr
Pre-Book The Polymerase Chain Reaction (PCR) Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Polymerase Chain Reaction (PCR) Market?
Leading firms in the polymerase chain reaction industry are advancing in the production of real-time polymerase chain reaction test kits to bolster accuracy, productivity, and user-friendly nature in genetic evaluation. The Real-time polymerase chain reaction (RT-PCR) test kit, an invention of the laboratory, is utilized to magnify and calculate precise DNA sequences immediately. For example, Cepheid, an American molecular diagnostics firm, introduced Xpert Xpress Multiplex Vaginal Panel (MVP) in November 2022. This FDA-approved multiplex PCR test can identify DNA from entities related to three unique vaginal infections - bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis, all from a single vaginal swab specimen. It supplements the functionality of classic polymerase chain reaction techniques by offering immediate monitoring, quantification, enhanced sensitivity and specificity. Hence, it is an irreplaceable apparatus in molecular biology and clinical diagnosis.
Who Are the Key Players In The Polymerase Chain Reaction (PCR) Market?
Major companies operating in the polymerase chain reaction (PCR) market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers GmbH
• Becton
• Dickinson and Company
• GE HealthCare Technologies Inc.
• Laboratory Corporation of America Holdings (LabCorp)
• Quest Diagnostics Incorporated
• Eurofins Scientific
• Agilent Technologies Inc.
• Illumina Inc.
• PerkinElmer Inc.
• bioMérieux SA
• Beckman Coulter Inc.
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Natera Inc.
• Myriad Genetics Inc.
• BGI Genomics Co. Ltd.
• Cepheid
• NeoGenomics Laboratories Inc.
• 23andMe Holding Co.
• Ambry Genetics Corporation
• Biocartis SA
• Centogene N.V.
• Veritas Genetics
What Is The Most Dominant Region In The Polymerase Chain Reaction (PCR) Market?
North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
